# Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma

> **NCT04305470** · PHASE3 · COMPLETED · sponsor: **NX Development Corp** · enrollment: 108 (actual)

## Conditions studied

- Meningioma

## Interventions

- **DRUG:** Gleolan

## Key facts

- **NCT ID:** NCT04305470
- **Lead sponsor:** NX Development Corp
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-28
- **Primary completion:** 2022-11-07
- **Final completion:** 2022-12-13
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305470, "Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04305470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*